0001179022-15-000084.txt : 20150708 0001179022-15-000084.hdr.sgml : 20150708 20150708165829 ACCESSION NUMBER: 0001179022-15-000084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150312 FILED AS OF DATE: 20150708 DATE AS OF CHANGE: 20150708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prelack Steven CENTRAL INDEX KEY: 0001302315 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 15979716 MAIL ADDRESS: STREET 1: 7 WHEELWRIGHT ROAD CITY: MEDFIELD STATE: MA ZIP: 02052 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-03-12 0001133416 GALECTIN THERAPEUTICS INC GALT 0001302315 Prelack Steven C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240 NORCROSS GA 30071 1 0 0 0 Common Stock 2015-03-12 4 A 0 11112 0 A 14048 D Common Stock 2015-04-08 4 A 0 2259 0 A 16307 D Common Stock 2015-04-08 4 A 0 90882 0 A 107189 D Stock Option (right to buy) 7.08 2015-04-08 4 D 0 6168 D 2021-06-28 Common Stock 6168 0 D Stock Option (right to buy) 3.59 2015-04-08 4 D 0 16714 D 2023-03-28 Common Stock 16714 0 D The option vested as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011. The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 19,504 shares of restricted common stock, reported in Table 1 of this Form 4 as a part of the April 8, 2015 grant of 90,882 shares, as consideration for the cancellation of options granted on June 28, 2011 and March 28, 2013. The option vested quarterly in eight equal installments beginning on May 12, 2013. /s/ Jack W. Callicutt as Power of Attorney for Steven Prelack 2015-07-08